Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials

Overview of attention for article published in Cardiovascular Diabetology, April 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 14,694 followers.

@cardioteca Estudio de una de las farmaceúticas q no aporta nada http://t.co/MlJKTcYnZp centrado en la enfermedad. Y vuestra frase final...

Tradjenta safe,effective for ppl w #type2diabete @ risk for #heart, #kidney disease. The #Pill_BOOK-15 p.420 http://t.co/jyF3Hq8YPN

Tradjenta safe,effective for ppl w #type2diabete @ risk for #heart, #kidney disease. The #Pill_BOOK-15 p.420 http://t.co/XllSBLUUZd

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.